Leader Biomedical Introduces Spine Portfolio with Targeted Therapeutic Solutions

Leader Biomedical introduces new Spine Portfolio with the launch of three targeted therapeutic solutions Adcon® Gel, Hyalosyn™ Gel, and Vebroplast® addressing adhesions, joint mobility, and vertebral compression fractures, respectively. Adcon® Gel is a biocompatible resorbable... - July 20, 2018

Leader Biomedical Announces Acquisition of International Orthopaedics Holding GmbH

Leader Biomedical is pleased to announce the phased acquisition of International Orthopaedics Holding GmbH (International Orthopaedics), a manufacturer and distributor of orthopaedic implants based in Geisingen, Germany. The companies have entered into a notarial deed on the 20th of February, 2018. - March 01, 2018

Press Releases 1 - 2 of 2